EMILIN2 down-modulates the Wnt signalling pathway and suppresses breast cancer cell growth and migration

Journal of Pathology

Volumn 232, Issue 4, 2014, Pages 391-404

  Marastoni, Stefano ^a   Andreuzzi, Eva ^a   Paulitti, Alice ^a   Colladel, Roberta ^a   Pellicani, Rosanna ^a   Todaro, Federico ^a   Schiavinato, Alvise ^b   Bonaldo, Paolo ^b   Colombatti, Alfonso ^a,c   Mongiat, Maurizio ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

breast cancer; EMILIN2; extracellular matrix; tumour microenvironment; Wnt signalling

Indexed keywords

ACTIN; BETA CATENIN; CHIR 99021; CYSTEINE; FRIZZLED PROTEIN; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; LITHIUM CHLORIDE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; PROTEIN EMILIN2; PROTEIN TAZ; RECOMBINANT PROTEIN; SCLEROPROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL VIABILITY; CONTROLLED STUDY; DELETION MUTANT; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

BREAST CANCER; EMILIN2; EXTRACELLULAR MATRIX; TUMOUR MICROENVIRONMENT; WNT SIGNALLING;

ANIMALS; BETA CATENIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HEK293 CELLS; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; MICE; MICE, NUDE; MUTATION; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR BURDEN; TUMOR MICROENVIRONMENT; WNT SIGNALING PATHWAY; WNT1 PROTEIN;

EID: 84893830229     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4316     Document Type: Article

References (50)

1. Hanahan D, Coussens LM,. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012; 21: 309-322.
2. Lu P, Weaver VM, Werb Z,. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 2012; 196: 395-406.
3. Paszek MJ, Zahir N, Johnson KR, et al., Tensional homeostasis and the malignant phenotype. Cancer Cell 2005; 8: 241-254. (Pubitemid 41317594)
4. DuFort CC, Paszek MJ, Weaver VM,. Balancing forces: architectural control of mechanotransduction. Nat Rev Mol Cell Biol 2011; 12: 308-319.
5. Hynes RO,. The extracellular matrix: not just pretty fibrils. Science 2009; 326: 1216-1219.
6. Braghetta P, Ferrari A, De GP, et al., Overlapping, complementary and site-specific expression pattern of genes of the EMILIN/Multimerin family. Matrix Biol 2004; 22: 549-556. (Pubitemid 38283778)
7. Doliana R, Bot S, Bonaldo P, et al., EMI, a novel cysteine-rich domain of EMILINs and other extracellular proteins, interacts with the gC1q domains and participates in multimerization. FEBS Lett 2000; 484: 164-168.
8. Doliana R, Canton A, Bucciotti F, et al., Structure, chromosomal localization, and promoter analysis of the human elastin microfibril interfase located protein (EMILIN) gene. J Biol Chem 2000; 275: 785-792. (Pubitemid 30051116)
9. Hill VK, Hesson LB, Dansranjavin T, et al., Identification of five novel genes methylated in breast and other epithelial cancers. Mol Cancer 2010; 9: 51.
10. Mongiat M, Ligresti G, Marastoni S, et al., Regulation of the extrinsic apoptotic pathway by the extracellular matrix glycoprotein EMILIN2. Mol Cell Biol 2007; 27: 7176-7187. (Pubitemid 47549753)
11. Mongiat M, Marastoni S, Ligresti G, et al., The extracellular matrix glycoprotein elastin microfibril interface located protein 2: a dual role in the tumor microenvironment. Neoplasia 2010; 12: 294-304.
12. Bronisz A, Godlewski J, Wallace JA, et al., Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol 2012; 14: 159-167.
13. Archbold HC, Yang YX, Chen L, et al., How do they do Wnt they do?: regulation of transcription by the Wnt/β-catenin pathway. Acta Physiol (Oxf) 2012; 204: 74-109.
14. Li VS, Ng SS, Boersema PJ, et al., Wnt Signaling through inhibition of β-catenin degradation in an intact Axin1 complex. Cell 2012; 149: 1245-1256.
15. Bhanot P, Brink M, Samos CH, et al., A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 1996; 382: 225-230.
16. Clevers H, Nusse R,. Wnt/β-catenin signaling and disease. Cell 2012; 149: 1192-1205.
17. Janda CY, Waghray D, Levin AM, et al., Structural basis of Wnt recognition by Frizzled. Science 2012; 337: 59-64.
18. Azzolin L, Zanconato F, Bresolin S, et al., Role of TAZ as mediator of Wnt signaling. Cell 2012; 151: 1443-1456.
19. Polakis P., The many ways of Wnt in cancer. Curr Opin Genet Dev 2007; 17: 45-51. (Pubitemid 46109296)
20. El WA, Lalli E,. The Wnt/β-catenin pathway in adrenocortical development and cancer. Mol Cell Endocrinol 2011; 332: 32-37.
21. Morris JP, Wang SC, Hebrok M,. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer 2010; 10: 683-695.
22. Armengol C, Cairo S, Fabre M, et al., Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model. Int J Biochem Cell Biol 2011; 43: 265-270.
23. Ge X, Wang X,. Role of Wnt canonical pathway in hematological malignancies. J Hematol Oncol 2010; 3: 33.
24. Hinoi T, Akyol A, Theisen BK, et al., Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. Cancer Res 2007; 67: 9721-9730. (Pubitemid 47621219)
25. Zardawi SJ, O'Toole SA, Sutherland RL, et al., Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. Histol Histopathol 2009; 24: 385-398.
26. Matsuda Y, Schlange T, Oakeley EJ, et al., WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res 2009; 11: R32.
27. Yook JI, Li XY, Ota I, et al., A Wnt-Axin2-GSK3β cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol 2006; 8: 1398-1406. (Pubitemid 44835115)
28. Wu W, Glinka A, Delius H, et al., Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/β-catenin signalling. Curr Biol 2000; 10: 1611-1614. (Pubitemid 32062666)
29. Spessotto P, Lacrima K, Nicolosi PA, et al., Fluorescence-based assays for in vitro analysis of cell adhesion and migration. Methods Mol Biol 2009; 522: 221-250.
30. Grande-Garcia A, Echarri A, de RJ, et al. Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases. J Cell Biol 2007; 177: 683-694. (Pubitemid 46799839)
31. Xu YK, Nusse R,. The Frizzled CRD domain is conserved in diverse proteins including several receptor tyrosine kinases. Curr Biol 1998; 8: R405-406. (Pubitemid 28286264)
32. Dann CE, Hsieh JC, Rattner A, et al., Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature 2001; 412: 86-90. (Pubitemid 32851515)
33. Bovolenta P, Esteve P, Ruiz JM, et al., Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J Cell Sci 2008; 121: 737-746. (Pubitemid 351578109)
34. Glinka A, Wu W, Delius H, et al., Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 1998; 391: 357-362. (Pubitemid 28093502)
35. MacDonald BT, Tamai K, He X,. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009; 17: 9-26.
36. Curtis C, Shah SP, Chin SF, et al., The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups. Nature 2012; 486: 346-352.
37. Berendsen AD, Fisher LW, Kilts TM, et al., Modulation of canonical Wnt signaling by the extracellular matrix component biglycan. Proc Natl Acad Sci USA 2011; 108: 17022-17027.
38. Capurro MI, Xiang YY, Lobe C, et al., Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res 2005; 65: 6245-6254. (Pubitemid 40994410)
39. Alexander CM, Reichsman F, Hinkes MT, et al., Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet 2000; 25: 329-332. (Pubitemid 30437323)
40. Ai X, Do AT, Lozynska O, et al., QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J Cell Biol 2003; 162: 341-351. (Pubitemid 36928846)
41. Lin X., Functions of heparan sulfate proteoglycans in cell signaling during development. Development 2004; 131: 6009-6021. (Pubitemid 40123916)
42. Quelard D, Lavergne E, Hendaoui I, et al., A cryptic frizzled module in cell surface collagen 18 inhibits Wnt/β-catenin signaling. PLoS One 2008; 3: e1878.
43. Yoshida T, Zhang Y, Rivera Rosado LA, et al., Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells. Mol Cancer Res 2009; 7: 1835-1844.
44. Nusse R, Varmus HE,. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982; 31: 99-109.
45. Lin SY, Xia W, Wang JC, et al., β-Catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 2000; 97: 4262-4266. (Pubitemid 30226121)
46. Bafico A, Liu G, Goldin L, et al., An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 2004; 6: 497-506. (Pubitemid 39469985)
47. Schlange T, Matsuda Y, Lienhard S, et al., Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res 2007; 9: R63.
48. Milovanovic T, Planutis K, Nguyen A, et al., Expression of Wnt genes and frizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma. Int J Oncol 2004; 25: 1337-1342.
49. Wong SC, Lo SF, Lee KC, et al., Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours. J Pathol 2002; 196: 145-153. (Pubitemid 34110895)
50. Shimo T, Kubota S, Yoshioka N, et al., Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer. J Bone Miner Res 2006; 21: 1045-1059. (Pubitemid 43962833)